|
|
|
|
|
|
|
|
|
|
"Heat (Biologics) is in phase 2 clinical trials studying its vaccine candidate HS-110 to treat non-small cell lung cancer. The company plans to start additional clinical studies in bladder and ovarian cancer this year."
Thursday, January 12, 2012
Heat Biologics: Vaccine biotech Heat Bio lands $250K; plans trials for bladder, ovarian cancers
"Heat (Biologics) is in phase 2 clinical trials studying its vaccine candidate HS-110 to treat non-small cell lung cancer. The company plans to start additional clinical studies in bladder and ovarian cancer this year."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.